期刊
MOLECULES
卷 21, 期 6, 页码 -出版社
MDPI
DOI: 10.3390/molecules21060762
关键词
biphenylurea; cytotoxic activity; indolinone; Lambda DME
资金
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Egyptian Russian University, Cairo, Egypt
- Deanship of Scientific Research at King Saud University through the Research Group Project [PRG-1436-038]
In our endeavor towards the development of potent anticancer agents, two different sets of biphenylurea-indolinone conjugates, 5a-s and 8a, b were synthesized. The in vitro cytotoxicity of the synthesized compounds was examined in two human cancer cell lines, namely MCF-7 breast cancer and PC-3 prostate cancer cells using the sulforhodamine B (SRB) colorimetric assay. In particular, the MCF-7 cancer cell line was more susceptible to the synthesized compounds. Compound 5o (IC50 = 1.04 +/- 0.10 mu M) emerged as the most active member in this study against MCF-7, with 7-fold increased activity compared to the reference drug, doxorubicin (IC50 = 7.30 +/- 0.84 mu M). Compounds 5l, 5q and 8b also exhibited superior cytotoxic activity against MCF-7 with IC50 values of 1.93 +/- 0.17, 3.87 +/- 0.31 and 4.66 +/- 0.42 mu M, respectively. All of the tested compounds were filtered according to the Lipinski and Veber rules and all of them passed the filters. Additionally, several ADME descriptors for the synthesized compounds 5a-s and 8a, b were predicted via a theoretical kinetic study performed using the Discovery Studio 2.5 software.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据